sl 01

SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.

SL 0101-1 (SL0101) 是一种可透过细胞膜且具有选择性、高效性、可逆性、ATP竞争性的 p90核糖体S6激酶(RSK) 的抑制剂，对 RSK 的 IC50 值为 89 nM。SL 0101-1 (SL0101) 也是一种有效的 RSK1 2 抑制剂，其 Ki 值为 1 μM。

SL-017 (ACP-SL-017, ACPSL-017, ACP-SL-017) is a Hypocrellin-B (Hb) derivative and photosensitization agent that may be used to treat abnormal hair growth. SL017 targets the mitochondria and causes the mitochondrial membrane potential to collapse, producin

3Ac-SL0101 is a potent RSK-specific inhibitor. It facilitates the development of RSK inhibitors as anti-cancer chemotherapeutic agents.